https://www.sciencedaily.com/news/health_medicine/pancreatic_cancer/ Read about the latest medical research concerning pancreatic cancer and other disorders of the pancreas. Consider new treatment options. en-us Fri, 10 Apr 2026 10:14:56 EDT Fri, 10 Apr 2026 10:14:56 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/pancreatic_cancer/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/03/260315225121.htm A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinical trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission. Mon, 16 Mar 2026 20:18:42 EDT https://www.sciencedaily.com/releases/2026/03/260315225121.htm https://www.sciencedaily.com/releases/2026/03/260303050624.htm Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more structured and treatable form—but it gets shut down by an overactive KRAS-driven pathway. When researchers blocked that pathway, GATA6 levels rebounded and cancer cells became more sensitive to chemo. The discovery could help turn some of the toughest pancreatic tumours into ones doctors can better control. Tue, 03 Mar 2026 11:33:04 EST https://www.sciencedaily.com/releases/2026/03/260303050624.htm https://www.sciencedaily.com/releases/2026/02/260212025620.htm A newly identified protein may hold the key to rejuvenating aging brain cells. Researchers found that boosting DMTF1 can restore the ability of neural stem cells to regenerate, even when age-related damage has set in. Without it, these cells struggle to renew and support memory and learning. The findings raise hopes for treatments that could slow or even reverse aspects of brain aging. Thu, 12 Feb 2026 09:42:41 EST https://www.sciencedaily.com/releases/2026/02/260212025620.htm https://www.sciencedaily.com/releases/2026/02/260206012229.htm Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are packed with immune-suppressing regulatory T cells. New research finally explains why. Scientists discovered that these T cells aren’t all the same: one subtype actually helps keep tumors in check, while another shields cancer from immune attack. The balance between these “good” and “bad” cells can determine whether a tumor grows or shrinks. Fri, 06 Feb 2026 11:03:34 EST https://www.sciencedaily.com/releases/2026/02/260206012229.htm https://www.sciencedaily.com/releases/2026/01/260129080432.htm Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a protein called periostin, the tumor remodels nearby tissue and invades nerves, which helps cancer cells travel and form metastases. This process also creates a tough, fibrous barrier that makes treatments less effective. Targeting periostin could help stop this invasion before it starts. Fri, 30 Jan 2026 07:44:14 EST https://www.sciencedaily.com/releases/2026/01/260129080432.htm https://www.sciencedaily.com/releases/2026/01/260114084129.htm Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat. Northwestern scientists discovered this hidden mechanism and created an antibody that strips away the tumor’s protective signal. In animal tests, immune cells sprang back into action and tumors grew much more slowly. The team is now refining the therapy for future human trials. Thu, 15 Jan 2026 02:10:05 EST https://www.sciencedaily.com/releases/2026/01/260114084129.htm https://www.sciencedaily.com/releases/2026/01/260108231333.htm Researchers have developed a new class of antibodies that amplify the immune system’s ability to fight cancer. By clustering immune receptors that normally receive weak signals from tumors, these four-pronged antibodies push T cells into full attack mode. In early studies, they outperformed conventional antibodies at activating cancer-killing immune cells. The work opens the door to more effective immunotherapy treatments. Fri, 09 Jan 2026 07:57:59 EST https://www.sciencedaily.com/releases/2026/01/260108231333.htm https://www.sciencedaily.com/releases/2025/12/251212204834.htm Researchers used AI to pinpoint a little-known monkeypox protein that provokes strong protective antibodies. When the team tested this protein as a vaccine ingredient in mice, it produced a potent immune response. The discovery could lead to simpler, more effective mpox vaccines and therapies. It may also help guide future efforts against smallpox. Fri, 12 Dec 2025 21:09:27 EST https://www.sciencedaily.com/releases/2025/12/251212204834.htm https://www.sciencedaily.com/releases/2025/11/251126095018.htm Researchers at Stanford found a way to cure or prevent Type 1 diabetes in mice using a combined blood stem cell and islet cell transplant. The procedure creates a hybrid immune system that stops autoimmune attacks and eliminates the need for immune-suppressing drugs. The method uses tools already common in clinical practice, putting human trials within reach. Scientists think the same strategy could transform treatments for autoimmune conditions and organ transplantation. Wed, 26 Nov 2025 12:05:21 EST https://www.sciencedaily.com/releases/2025/11/251126095018.htm https://www.sciencedaily.com/releases/2025/11/251107010324.htm A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, removes diseased stem cells without radiation, enabling nearly complete donor cell replacement. The approach also widens donor eligibility and could soon be applied to other bone marrow failure diseases. Fri, 07 Nov 2025 22:28:44 EST https://www.sciencedaily.com/releases/2025/11/251107010324.htm https://www.sciencedaily.com/releases/2025/10/251029100156.htm Flatworms can rebuild themselves from just a small fragment, and now scientists know why. Their stem cells ignore nearby instructions and respond to long-distance signals from other tissues. This discovery turns old stem cell theories upside down and could lead to new ways to repair or regrow human tissue. It also reveals a hidden complexity in one of nature’s simplest creatures. Wed, 29 Oct 2025 10:01:56 EDT https://www.sciencedaily.com/releases/2025/10/251029100156.htm https://www.sciencedaily.com/releases/2025/10/251004092858.htm A Weill Cornell Medicine team has found that triple-negative breast cancer depends on the enzyme EZH2 to spread. By silencing key genes, EZH2 drives chaotic cell divisions and fuels metastasis. Blocking EZH2 restored stability and prevented cancer cells from traveling to distant organs. This discovery opens the door to new therapies that may finally tame this aggressive disease. Sat, 04 Oct 2025 11:05:19 EDT https://www.sciencedaily.com/releases/2025/10/251004092858.htm https://www.sciencedaily.com/releases/2025/09/250922074954.htm Researchers found that pancreatic pre-cancer cells mimic dementia by forming clumps of proteins due to faulty recycling processes. These insights could shed light on why pancreatic cancer develops so aggressively and why it is difficult to treat. By studying overlaps with neurological diseases, scientists hope to identify new strategies for prevention and treatment. Mon, 22 Sep 2025 23:30:44 EDT https://www.sciencedaily.com/releases/2025/09/250922074954.htm https://www.sciencedaily.com/releases/2025/09/250902085154.htm Scientists have decoded the 3D structure of an ancient viral protein hidden in our DNA. The HERV-K Env protein, found on cancer and autoimmune cells, has a unique shape that could unlock new diagnostics and therapies. Wed, 03 Sep 2025 03:54:43 EDT https://www.sciencedaily.com/releases/2025/09/250902085154.htm https://www.sciencedaily.com/releases/2025/07/250711224312.htm A team at Scripps Research has created a microchip that can rapidly reveal how a person's antibodies respond to viruses using only a drop of blood. This game-changing technology, called mEM, condenses a week’s worth of lab work into 90 minutes, offering a powerful tool for tracking immune responses and fast-tracking vaccine development. Unlike earlier methods, it needs far less blood and delivers more detailed insights, even revealing previously undetected antibody targets on viruses like SARS-CoV-2 and influenza. Sat, 12 Jul 2025 02:58:23 EDT https://www.sciencedaily.com/releases/2025/07/250711224312.htm https://www.sciencedaily.com/releases/2025/05/250529124610.htm Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer. The new study's findings in The American Journal of Pathology, published by Elsevier, found that C5aR1 promotes the invasion of cSCC tumor cells. Its elevated presence suggests that C5aR1 might serve as a useful prognostic marker for metastatic disease and, potentially, a target for future therapies in advanced cSCC. Thu, 29 May 2025 12:46:10 EDT https://www.sciencedaily.com/releases/2025/05/250529124610.htm https://www.sciencedaily.com/releases/2025/05/250523120353.htm Researchers have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance promises to improve diabetes research and cell-based therapies. Fri, 23 May 2025 12:03:53 EDT https://www.sciencedaily.com/releases/2025/05/250523120353.htm https://www.sciencedaily.com/releases/2025/05/250521124626.htm New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies. Wed, 21 May 2025 12:46:26 EDT https://www.sciencedaily.com/releases/2025/05/250521124626.htm https://www.sciencedaily.com/releases/2025/05/250521124301.htm A study explains how age reshapes the blood system. In both humans and mice, a few stem cells out-compete their neighbors and gradually take over blood production. The loss of diversity results in a blood system that has a preference for producing myeloid cells, immune cells linked to chronic inflammation which underlies many different diseases. Using a new technique, researchers tracked naturally-occurring 'barcodes' in blood cells which can lead to new strategies that spot early warning signs of unhealthy aging long before symptoms appear, helping prevent cancer or heart disease. The technique also opens the door to studying the viability of rejuvenation therapies in humans, efforts which have traditionally been the focus of animal research. Wed, 21 May 2025 12:43:01 EDT https://www.sciencedaily.com/releases/2025/05/250521124301.htm https://www.sciencedaily.com/releases/2025/05/250520224245.htm Scientists and medics have developed an ultra-rapid method of genetically diagnosing brain tumors that will cut the time it takes to classify them from 6-8 weeks, to as little as two hours.The team utilized the new approach during 50 brain tumor surgeries to deliver rapid, intraoperative diagnoses. This approach has achieved a 100% success rate, providing diagnostic results in under two hours from surgery and detailed tumor classifications within minutes of sequencing. Tue, 20 May 2025 22:42:45 EDT https://www.sciencedaily.com/releases/2025/05/250520224245.htm https://www.sciencedaily.com/releases/2025/05/250514180735.htm Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, stroke or heart attack, a new study shows. The finding might help clinicians determine which patients may need early treatment and clinical monitoring for thrombotic events. Wed, 14 May 2025 18:07:35 EDT https://www.sciencedaily.com/releases/2025/05/250514180735.htm https://www.sciencedaily.com/releases/2025/05/250508161144.htm Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study. Thu, 08 May 2025 16:11:44 EDT https://www.sciencedaily.com/releases/2025/05/250508161144.htm https://www.sciencedaily.com/releases/2025/05/250501122441.htm Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease. Thu, 01 May 2025 12:24:41 EDT https://www.sciencedaily.com/releases/2025/05/250501122441.htm https://www.sciencedaily.com/releases/2025/04/250424165403.htm 'Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice. Thu, 24 Apr 2025 16:54:03 EDT https://www.sciencedaily.com/releases/2025/04/250424165403.htm https://www.sciencedaily.com/releases/2025/04/250423185925.htm Researchers have discovered that expansion of mutant blood cells, a phenomenon linked to aging, can be found in cancerous tumors, and this is associated with worse outcomes for patients. Wed, 23 Apr 2025 18:59:25 EDT https://www.sciencedaily.com/releases/2025/04/250423185925.htm https://www.sciencedaily.com/releases/2025/04/250422132004.htm Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of the immune system, which then go to work to clear an infection. A new study explores the factors that influence how effectively antibodies engage specific immune cells. Tue, 22 Apr 2025 13:20:04 EDT https://www.sciencedaily.com/releases/2025/04/250422132004.htm https://www.sciencedaily.com/releases/2025/04/250402122018.htm Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to prevent pancreatic cancer from forming in the first place. Wed, 02 Apr 2025 12:20:18 EDT https://www.sciencedaily.com/releases/2025/04/250402122018.htm https://www.sciencedaily.com/releases/2025/03/250325160113.htm Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies. Many proteins group together in what are called protein complexes to carry out biological functions. The traditional method of generating antibodies by immunizing animals struggles to make antibodies related to these protein complexes. Scientists have now demonstrated that fusing protein complexes together adds stability during immunization and enables antibody generation. Tue, 25 Mar 2025 16:01:13 EDT https://www.sciencedaily.com/releases/2025/03/250325160113.htm https://www.sciencedaily.com/releases/2025/03/250319143531.htm An innovative platform replicates pancreatic functions, transforming diabetes therapy. Wed, 19 Mar 2025 14:35:31 EDT https://www.sciencedaily.com/releases/2025/03/250319143531.htm https://www.sciencedaily.com/releases/2025/03/250318141555.htm New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies simultaneously in a single mouse. This should not only speed up the research and development pipeline for new drugs, but also hugely reduce the number of laboratory animals required. Tue, 18 Mar 2025 14:15:55 EDT https://www.sciencedaily.com/releases/2025/03/250318141555.htm https://www.sciencedaily.com/releases/2025/03/250313130948.htm A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new research. Thu, 13 Mar 2025 13:09:48 EDT https://www.sciencedaily.com/releases/2025/03/250313130948.htm https://www.sciencedaily.com/releases/2025/03/250310152912.htm In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research shows that the combination of certain viral antibodies and genetic risk factors can be linked to a greatly increased risk of MS. Mon, 10 Mar 2025 15:29:12 EDT https://www.sciencedaily.com/releases/2025/03/250310152912.htm https://www.sciencedaily.com/releases/2025/03/250310131639.htm A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study. The discovery could lead to more effective bone marrow transplants and gene therapies. Mon, 10 Mar 2025 13:16:39 EDT https://www.sciencedaily.com/releases/2025/03/250310131639.htm https://www.sciencedaily.com/releases/2025/03/250305164351.htm A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the approach shows promise in developing treatments to keep pace with evolving viruses. Wed, 05 Mar 2025 16:43:51 EST https://www.sciencedaily.com/releases/2025/03/250305164351.htm https://www.sciencedaily.com/releases/2025/03/250305134822.htm Cambridge researchers found that aspirin may help the immune system stop cancer from spreading. It works by turning off a signal that usually quiets down immune cells, giving them the power to destroy roaming cancer cells. The finding could lead to new, affordable ways to prevent cancer from coming back — but doctors warn aspirin can have side effects, so it shouldn’t be taken without medical advice. Wed, 05 Mar 2025 13:48:22 EST https://www.sciencedaily.com/releases/2025/03/250305134822.htm https://www.sciencedaily.com/releases/2025/02/250225122033.htm New findings question assumptions of cancer formation in individuals with the cancer-predisposition syndrome, neurofibromatosis type 1, and offer hope for a personalized approach to early cancer recognition including for those with similar conditions. Tue, 25 Feb 2025 12:20:33 EST https://www.sciencedaily.com/releases/2025/02/250225122033.htm https://www.sciencedaily.com/releases/2025/02/250218113655.htm Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. Early detection of PC is the primary concern of most PC research, as it has the potential to make a substantial difference to the treatment and survival of patients. Survival rates, however, remain poor due to the vague nature of the symptoms associated with early-stage PC, and subsequently the late-stage of the disease at diagnosis. Now researchers are focusing on pancreatic cystic lesions to tackle the crucial issue of identifying patients who are at high-risk of developing pancreatic cancer, to improve survival rates. Tue, 18 Feb 2025 11:36:55 EST https://www.sciencedaily.com/releases/2025/02/250218113655.htm https://www.sciencedaily.com/releases/2025/02/250212192458.htm Researchers have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose blood thinners. Wed, 12 Feb 2025 19:24:58 EST https://www.sciencedaily.com/releases/2025/02/250212192458.htm https://www.sciencedaily.com/releases/2025/02/250212151141.htm A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers. Wed, 12 Feb 2025 15:11:41 EST https://www.sciencedaily.com/releases/2025/02/250212151141.htm https://www.sciencedaily.com/releases/2025/02/250210133016.htm Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues. Mon, 10 Feb 2025 13:30:16 EST https://www.sciencedaily.com/releases/2025/02/250210133016.htm https://www.sciencedaily.com/releases/2025/02/250207133429.htm A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research. Fri, 07 Feb 2025 13:34:29 EST https://www.sciencedaily.com/releases/2025/02/250207133429.htm https://www.sciencedaily.com/releases/2025/02/250207122748.htm Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies, and clues behind why these tumors don't respond to existing immunotherapies. Fri, 07 Feb 2025 12:27:48 EST https://www.sciencedaily.com/releases/2025/02/250207122748.htm https://www.sciencedaily.com/releases/2025/02/250204132410.htm A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block it. Tue, 04 Feb 2025 13:24:10 EST https://www.sciencedaily.com/releases/2025/02/250204132410.htm https://www.sciencedaily.com/releases/2025/01/250128162827.htm A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to rethink current screening guidelines for detecting brain metastasis in patients without symptoms. Tue, 28 Jan 2025 16:28:27 EST https://www.sciencedaily.com/releases/2025/01/250128162827.htm https://www.sciencedaily.com/releases/2025/01/250123110236.htm New research looked at how cancers arise in children who are predisposed to developing the childhood kidney cancer, Wilms tumor, which could help anticipate the development of tumors before they fully form. Thu, 23 Jan 2025 11:02:36 EST https://www.sciencedaily.com/releases/2025/01/250123110236.htm https://www.sciencedaily.com/releases/2025/01/250120113756.htm Researchers have determined how children's immune systems react to different kinds of cancer depending on their age. The study reveals significant differences between the immune response of children and adults, and has the potential to lead to new tailored treatments for children with cancer. Mon, 20 Jan 2025 11:37:56 EST https://www.sciencedaily.com/releases/2025/01/250120113756.htm https://www.sciencedaily.com/releases/2025/01/250117161118.htm Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection. But scientists have now discovered that for some HIV vaccines, something else happens: after a few immunizations the immune system begins to produce antibodies against immune complexes already bound to the viral protein alone. Fri, 17 Jan 2025 16:11:18 EST https://www.sciencedaily.com/releases/2025/01/250117161118.htm https://www.sciencedaily.com/releases/2025/01/250110122027.htm A look at cancer cells: Thanks to an innovative method of super-resolution microscopy, researchers observed with molecular resolution in 3D how therapeutic antibodies attack and alter B cells, thereby inducing their destruction. Their research presents the new type of molecular 3D visualization of antibody-cell interactions. The visualization of the molecular interaction between antibody and tumor cell opens up new avenues for improved immunotherapies against cancer. Fri, 10 Jan 2025 12:20:27 EST https://www.sciencedaily.com/releases/2025/01/250110122027.htm https://www.sciencedaily.com/releases/2025/01/250110121913.htm Scientists have discovered that T cells -- white blood cells that can destroy harmful pathogens -- can completely prevent viral infection, to an extent previously thought only possible due to neutralizing antibodies. Their findings reshape our understanding of how our immune system works, paving the way for the design of more effective vaccines. Fri, 10 Jan 2025 12:19:13 EST https://www.sciencedaily.com/releases/2025/01/250110121913.htm https://www.sciencedaily.com/releases/2025/01/250109125840.htm Cancer metastasis -- the spread of cancer to other organs -- is the leading cause of death among cancer patients. Researchers have now uncovered a 'genetic signature' of 177 genes shared across multiple cancer types that drives this deadly process. Thu, 09 Jan 2025 12:58:40 EST https://www.sciencedaily.com/releases/2025/01/250109125840.htm https://www.sciencedaily.com/releases/2024/12/241217131240.htm Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer. Tue, 17 Dec 2024 13:12:40 EST https://www.sciencedaily.com/releases/2024/12/241217131240.htm https://www.sciencedaily.com/releases/2024/12/241213125202.htm Researchers are shining a light on cancer cells' energy centers -- literally -- to damage these power sources and trigger widespread cancer cell death. In a new study, scientists combined strategies to deliver energy-disrupting gene therapy using nanoparticles manufactured to zero in only on cancer cells. Experiments showed the targeted therapy is effective at shrinking glioblastoma brain tumors and aggressive breast cancer tumors in mice. Fri, 13 Dec 2024 12:52:02 EST https://www.sciencedaily.com/releases/2024/12/241213125202.htm https://www.sciencedaily.com/releases/2024/12/241211124508.htm Gut microbiome composition during pregnancy has long-term effects on offspring stem cell growth and development, researchers report. Treating pregnant mice with a common gut microbe resulted in offspring that had more active stem cells in both the brain and intestinal tract. As a result, the offspring were less anxious and recovered quicker from colitis, and these differences were still evident at 10 months of age. Wed, 11 Dec 2024 12:45:08 EST https://www.sciencedaily.com/releases/2024/12/241211124508.htm https://www.sciencedaily.com/releases/2024/12/241211124345.htm Scientists' findings in mice could translate into a radical, needle-free vaccination approach that would also eliminate reactions including fever, swelling and pain. Wed, 11 Dec 2024 12:43:45 EST https://www.sciencedaily.com/releases/2024/12/241211124345.htm https://www.sciencedaily.com/releases/2024/12/241209122548.htm Metastasis is responsible for 90 percent of cancer deaths. Researchers have found that the mutations driving it may stem from a commonly inherited variant of the PCSK9 gene. Mon, 09 Dec 2024 12:25:48 EST https://www.sciencedaily.com/releases/2024/12/241209122548.htm https://www.sciencedaily.com/releases/2024/12/241205184442.htm Researchers have found a new receptor for nerve growth factor that plays an important role in pain signaling, even though it does not signal on its own, according to a new study. The findings hold promise for finding new treatments for arthritis and other forms of inflammatory and cancer pain, without the side effects that led recent therapies to fail in clinical trials. Thu, 05 Dec 2024 18:44:42 EST https://www.sciencedaily.com/releases/2024/12/241205184442.htm https://www.sciencedaily.com/releases/2024/12/241203194354.htm Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumors have a long-term benefit for at least 20 years, while the benefit was more short-term for younger women with similar tumor characteristics who had not yet gone through the menopause. Tue, 03 Dec 2024 19:43:54 EST https://www.sciencedaily.com/releases/2024/12/241203194354.htm https://www.sciencedaily.com/releases/2024/12/241203154442.htm Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the tumor to the liver, according to a new study. The discovery improves the scientific understanding of cancer progression and anticancer immunity, and could yield new clinical tools for assessing and reducing metastasis risk. Tue, 03 Dec 2024 15:44:42 EST https://www.sciencedaily.com/releases/2024/12/241203154442.htm https://www.sciencedaily.com/releases/2024/12/241202123642.htm Researchers uncover how two mechano-sensing ion channels are essential to maintain healthy stem cells. Mon, 02 Dec 2024 12:36:42 EST https://www.sciencedaily.com/releases/2024/12/241202123642.htm https://www.sciencedaily.com/releases/2024/12/241202123340.htm Researchers have developed a new organoid that mimics the human fetal pancreas, offering a clearer view of its early development. The researchers were able to recreate a complete structure that includes the three key cell types in the pancreas, which previous organoids couldn't fully mimic. Mon, 02 Dec 2024 12:33:40 EST https://www.sciencedaily.com/releases/2024/12/241202123340.htm